Aero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery Applications
Now available for licensing, Ultra Soft Nasal Pump Spray leverages innovative spray nozzle chip technology for superior nasal cavity coverage—ideal for nose to brain therapies, vaccination, and other advanced multidose nasal applications, mehr …
www.now-magazine.de/content/93774/aero-pump-and-resyca-partner-to-launch-ultra-soft-nasal-pump-spray-targeting-precise-nasal-drug-delivery-applications.html
Enterin to Announce Top-Line Results From the Phase 2b Study for Parkinson’s Disease
Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for neurodegenerative and metabolic diseases, today announced that it will host a webinar to present top-line results from the Phase 2b (KARMET) study in patients with Parkinson’s disease on Thursday, Jan. 27 at 2:30 pm EST, mehr …
www.now-magazine.de/content/35483/enterin-to-announce-top-line-results-from-the-phase-2b-study-for-parkinsons-disease.html
SVHI PRP Therapy Announces Updated Page Content for PRP for Hair Loss in Foster City
SVHI PRP Therapy is proud to announce new content for its PRP for hair loss on the Foster City page. The relationship between skin and hair trouble can lead to hair loss solutions, mehr …
www.now-magazine.de/content/41408/svhi-prp-therapy-announces-updated-page-content-for-prp-for-hair-loss-in-foster-city.html
New clinical study realized with a Belgian supplement shows promising results against Covid 19
A daily intake of a new dietary supplement (Nasafytol) containing an oral combination of Quercetin (65 milligrams), Curcumin (42 milligrams) and Vitamin D 3 (2.2 micrograms) for 14 days by early-stage mild to moderately symptomatic Covid 19 outpatients, resulted in more rapid clearance of the SARS-CoV-2 viral infection, more rapid resolution of Covid 19 associated acute symptoms and more rapid improvement in the inflammatory marker CRP levels; leading to speedier recovery of the patients, mehr …
www.now-magazine.de/content/51668/new-clinical-study-realized-with-a-belgian-supplement-shows-promising-results-against-covid-19.html
Treatment of ovarian cancer in Germany
Ovarian cancer is diagnosed at advanced stages and spreads rapidly throughout the peritoneum. This cancer is difficult to treat, but it is quite possible if you receive medical care in one of the developed countries in the world, mehr …
www.now-magazine.de/content/53591/treatment-of-ovarian-cancer-in-germany.html
Heartseed and Novo Nordisk announce first patient dosed in clinical study with HS-001—a cell therapy designed to restore heart function in people with advanced heart failure
HS 001 consists of clusters of purified heart muscle cells derived from induced pluripotent stem cells (iPSCs), mehr …
www.now-magazine.de/content/58964/heartseed-and-novo-nordisk-announce-first-patient-dosed-in-clinical-study-with-hs-001-a-cell-therapy-designed-to-restore-heart-function-in-people-with-advanced-heart-failure.html
Novo Nordisk to Expand R & D Presence in Greater Boston Area
Novo Nordisk just announced plans to expand its research and development (R & D) presence in the greater Boston metro area, creating one of its largest R & D hubs outside of Denmark, mehr …
www.now-magazine.de/content/60535/novo-nordisk-to-expand-r-und-d-presence-in-greater-boston-area.html
Depression: Gesprächstherapie gut fürs Herz, bei Patienten unter 60 Jahren verringert sich das Risiko von Herz Kreislauf Leiden um 15 Prozent
Gesprächstherapien wie die kognitive Verhaltenstherapie (CBT) zur Behandlung von Depressionen bei Erwachsenen über 45 Jahren, stehen mit weniger Herz Kreislauf Erkrankungen in der Zukunft in Zusammenhang, mehr …
www.now-magazine.de/content/64250/depression-gespraechstherapie-gut-fuers-herz-bei-patienten-unter-60-jahren-verringert-sich-das-risiko-von-herz-kreislauf-leiden-um-15-prozent.html
Aronora Secures Investment From New York Blood Center
Aronora is Revolutionizing Blood Clot Treatment with Groundbreaking Innovations, mehr …
www.now-magazine.de/content/76749/aronora-secures-investment-from-new-york-blood-center.html
GB Sciences Signs Licensing Deal With «EndoPure« Life Sciences for 5 Percent Gross Sales Royalty & Sponsorship of First in Human Trial for Their Cannabinoid Based Parkinson’s Drug
As a part of their Exclusive Licensing Deal, “EndoPure” Life Sciences will finance and sponsor first in human clinical trials, which help to advance GB Sciences’ cannabinoid based products globally, mehr …
www.now-magazine.de/content/94248/gb-sciences-signs-licensing-deal-with-endopure-life-sciences-for-5-percent-gross-sales-royalty-und-sponsorship-of-first-in-human-trial-for-their-cannabinoid-based-parkinsons-drug.html
Mahatma Gandhi Cancer Hospital and Research Institute: World Cancer Day on February 4th, 2025
Join us for the World Cancer Day 2025 Walkathon in #Visakhapatnam, organized by Mahatma Gandhi Cancer Hospital and Research Institute and Shreya Cancer Foundation, mehr …
www.now-magazine.de/content/97734/mahatma-gandhi-cancer-hospital-and-research-institute-world-cancer-day-on-february-4th-2025.html
The Freedom to Breathe: Reenabling naturally healthy breathing through Subtle Body Balance by the Goethert Method
Why our subtle body is the key to naturally healthy breathing—and how it can be integrated into breathing practice, mehr …
www.now-magazine.de/content/112549/the-freedom-to-breathe-reenabling-naturally-healthy-breathing-through-subtle-body-balance-by-the-goethert-method.html
Scalar Field Therapy and Mitigation of Seizure Disorder: A Case Report
This case report describes a 4 year and 10 month old child with autism and intractable epilepsy who experienced frequent tonic clonic and partial seizures despite medication, mehr …
www.now-magazine.de/content/115293/scalar-field-therapy-and-mitigation-of-seizure-disorder-a-case-report.html
